Dog Protein-Losing Nephropathy Management

Protein-losing nephropathy (PLN) causes progressive kidney damage with significant welfare implications, requiring early detection, targeted treatment, and careful long-term management.

Key Facts

PLN is characterized by abnormal protein loss through damaged glomeruli, causing hypoalbuminemia and progressive renal disease
Soft Coated Wheaten Terriers, Bernese Mountain Dogs, and Rottweilers have genetic predispositions to PLN
Clinical signs include edema, ascites, weight loss, and eventually signs of chronic kidney disease
Urine protein:creatinine ratio (UPC) is the primary monitoring tool - ratios above 0.5 indicate significant proteinuria
Treatment may include ACE inhibitors, omega-3 fatty acids, low-protein diets, and immunosuppression for immune-mediated forms

Welfare Considerations

PLN is a chronic welfare challenge requiring long-term management of multiple interrelated problems - proteinuria, hypoalbuminemia, hypertension, thromboembolism risk, and progressive renal insufficiency. Each complication has welfare implications: edema causes discomfort, hypertension contributes to vision loss, and renal failure causes nausea and fatigue. Structured monitoring with regular UPC, blood pressure, and albumin measurements enables early intervention that significantly slows disease progression and preserves quality of life.

What You Can Do

Have high-risk breeds screened for PLN annually from age 3-4 with urine protein:creatinine ratio testing
Work with an internal medicine specialist for diagnosis and initial treatment planning
Monitor blood pressure in dogs with PLN - hypertension is a major welfare and disease progression factor
Feed a prescription renal diet when kidney function becomes impaired
Assess quality of life regularly and discuss palliative care options when disease becomes advanced